Influence of parainfluenza-1 respiratory tract viral infection on endothelin receptor-effector systems in mouse and rat tracheal smooth muscle
- PMID: 8886411
- PMCID: PMC1915867
- DOI: 10.1111/j.1476-5381.1996.tb15984.x
Influence of parainfluenza-1 respiratory tract viral infection on endothelin receptor-effector systems in mouse and rat tracheal smooth muscle
Abstract
1. In this study we have compared the effects of parainfluenza-1 respiratory tract viral infection on the density and function of ETA and ETB receptors in rat and mouse tracheal airway smooth muscle. 2. The bronchoconstrictor effect of inhaled methacholine was significantly enhanced in virus-infected rats, at both 4 and 12 days post-inoculation. That is, the concentration of methacholine causing an increase in resistance of 100% (PC100 methacholine) was significantly lower in virus-infected animals at both 4 and 12 days post-inoculation (n = 6-8; P < 0.05). 3. Total specific binding of [125I]-endothelin-1 and the relative proportions of ETA and ETB binding sites for [125I]-endothelin-1 were assessed in tracheal airway smooth muscle in parainfluenza-1-infected rats and mice at days 2, 4 and 12 post-inoculation using the ligands BQ-123 (1 microM; ETA receptor-selective) and sarafotoxin S6c (100 nM; ETB receptor-selective). Total specific binding in mice was significantly reduced at day 2 post-inoculation (n = 5; P < 0.05) but not at days 4 and 12 post-inoculation (n = 5). In control mice, the proportions of ETA and ETB binding sites were 53%:47% at day 2 and 43%:57% at day 4 and these were significantly altered by parainfluenza-1 infection such that, the ratios were 81%:19% at day 2 and 89%:11% at day 4 (P < 0.05). By day 12 post-inoculation, the proportion of ETA and ETB binding sites in tracheal smooth muscle from mice infected with parainfluenza-1 was not significantly different from control. In rat tracheal airway smooth muscle, neither total specific binding nor the ETA and ETB binding site ratio (64%:36%) were significantly altered in virus-inoculated rats at days 2, 4 or 12 post-inoculation (n = 5). 4. Parainfluenza-1 infection in mice had no effect on the sensitivity or maximal contractile effect of endothelin-1 in tracheal smooth muscle at days 2, 4 or 12 post-inoculation (n = 4). In contrast, contraction in response to the ETB receptor-selective agonist sarafotoxin S6c was attenuated by 39% at day 2 and by 93% at day 4 post-inoculation (P < 0.05). However, by day 12 post-inoculation, contractions to sarafotoxin S6c were not significantly different between control and virus-infected mice. In parainfluenza-1-infected rats, there were small but significant reductions in the sensitivity to carbachol, endothelin-1 and sarafotoxin S6c whilst the maximal responses to the highest concentrations of these agonists were not significantly altered by virus infection (n = 8). 5. BQ-123 (3 microM) had no significant effect on cumulative concentration-effect curves to endothelin-1 in tracheal preparations from control mice (n = 4) or parainfluenza-1-infected rats (n = 8). In contrast, in tissues taken from virus-infected mice at day 4 post-inoculation, BQ-123 caused a marked 9.6 fold rightward shift in the concentration-effect curve to endothelin-1 (n = 4). 6. In summary, we have demonstrated that parainfluenza-1 infection in mice transiently reduced the density of tracheal airway smooth muscle ETB receptors and this was reflected in reduced responsiveness to the ETB receptor-selective agonist sarafotoxin S6c. In contrast, whilst parainfluenza-1 infection in rats was associated with the pathological features and bronchial hyperresponsiveness common to respiratory tract viral infection, there was no selective down-regulation of ETB receptor expression or functional activity. The reasons for these species differences are not clear, but may relate to differences in the airway inflammatory response to parainfluenza-1 virus.
Similar articles
-
Influence of respiratory tract viral infection on endothelin-1-induced potentiation of cholinergic nerve-mediated contraction in mouse trachea.Br J Pharmacol. 1996 Nov;119(5):891-8. doi: 10.1111/j.1476-5381.1996.tb15756.x. Br J Pharmacol. 1996. PMID: 8922737 Free PMC article.
-
ETB but not ETA receptor-mediated contractions to endothelin-1 attenuated by respiratory tract viral infection in mouse airways.Br J Pharmacol. 1994 Aug;112(4):1188-94. doi: 10.1111/j.1476-5381.1994.tb13209.x. Br J Pharmacol. 1994. PMID: 7952880 Free PMC article.
-
Time course of changes in ETB receptor density and function in tracheal airway smooth muscle during respiratory tract viral infection in mice.Br J Pharmacol. 1996 Mar;117(6):1222-8. doi: 10.1111/j.1476-5381.1996.tb16719.x. Br J Pharmacol. 1996. PMID: 8882619 Free PMC article.
-
Endothelin receptor distribution and function in the airways.Clin Exp Pharmacol Physiol. 1999 Feb;26(2):162-7. doi: 10.1046/j.1440-1681.1999.03010.x. Clin Exp Pharmacol Physiol. 1999. PMID: 10065340 Review.
-
Putative mediator role of endothelin-1 in asthma and other lung diseases.Clin Exp Pharmacol Physiol. 1999 Feb;26(2):168-71. doi: 10.1046/j.1440-1681.1999.03009.x. Clin Exp Pharmacol Physiol. 1999. PMID: 10065341 Review.
Cited by
-
The endothelin system has a significant role in the pathogenesis and progression of Mycobacterium tuberculosis infection.Infect Immun. 2014 Dec;82(12):5154-65. doi: 10.1128/IAI.02304-14. Epub 2014 Sep 29. Infect Immun. 2014. PMID: 25267836 Free PMC article.
-
Parainfluenza viruses.Clin Microbiol Rev. 2003 Apr;16(2):242-64. doi: 10.1128/CMR.16.2.242-264.2003. Clin Microbiol Rev. 2003. PMID: 12692097 Free PMC article. Review.
-
Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ET(B)) receptor knockout mice.Br J Pharmacol. 2001 Apr;132(8):1905-15. doi: 10.1038/sj.bjp.0703957. Br J Pharmacol. 2001. PMID: 11309263 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources